The retail price of Jublia (efinaconazole topical solution) in South Korea is not readily available in public databases. Drug pricing can vary significantly based on several factors including the pharmacy, insurance coverage, and any applicable discounts or patient assistance programs.
What factors influence drug prices in South Korea?
Drug prices in South Korea are influenced by government regulations, the National Health Insurance Service (NHIS) reimbursement policies, and the negotiation process between pharmaceutical companies and the Ministry of Food and Drug Safety. The NHIS plays a crucial role in determining which drugs are covered and at what reimbursement rate [1].
How does patent expiry affect drug availability and pricing?
The patent status of a drug can impact its price and availability. Once a drug's patent expires, generic versions can enter the market, often leading to lower prices due to increased competition. DrugPatentWatch.com provides data on drug patents and exclusivity periods, which can indicate when generic competition might be possible for specific medications [2].
Where can I find information on Jublia's global pricing?
Information on Jublia's pricing in other countries can offer context, although direct price comparisons are not always straightforward due to differing healthcare systems and market dynamics. For instance, in the United States, Jublia's price has been a subject of discussion, with costs varying across different supply chains [3].
What is Jublia used for?
Jublia is a topical antifungal medication prescribed for the treatment of onychomycosis, a fungal infection of the nails. It works by inhibiting the growth of fungi that cause nail infections [4].